Outcomes from a phase I trial of an adenovirus/PSA vaccine for prostate cancer

被引：3
|
作者：
Lubaroff, David M.
Konety, Badrinath R.
Link, Brian K.
Ratliff, Timothy L.
Madsen, Tammy
Williams, Richard D.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60534-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [1] A phase II trial of an adenovirus/PSA vaccine for prostate cancer
    Lubaroff, D. M.
    Vaena, D. A.
    Williams, R. D.
    Joudi, F. N.
    Smith, M. C.
    Zehr, P. S.
    Eastman, J.
    Griffith, K.
    Madsen, T. M.
    Johnson, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] An ongoing Phase II trial of an adenovirus/PSA vaccine for prostate cancer
    Lubaroff, David M.
    Williams, Richard D.
    Vaena, Daniel
    Joudi, Fadi
    Brown, James
    Smith, Mark
    Zehr, Pamela
    Brown, Erica
    Eastman, Julie
    Griffith, Karen
    Madsen, Tammy
    Johnson, Kristine
    CANCER RESEARCH, 2012, 72
  • [3] Clinical and Immune Data From an Ongoing Phase II Trial of an Adenovirus/PSA Vaccine for Prostate Cancer
    Lubaroff, David M.
    Williams, Richard D.
    Vaena, Daniel
    Joudi, Fadi
    Smith, Mark
    Zehr, Pamela
    Flanders, Erica
    Eastman, Julie
    Griffith, Karen
    Madsen, Tammy
    Johnson, Christine
    CANCER RESEARCH, 2010, 70
  • [4] Preliminary results of a phase II trial of an adenovirus/PSA vaccine in men with recurrent prostate cancer
    Lubaroff, David M.
    Vaena, Daniel
    Brown, James
    Nepple, Kenneth
    Zehr, Pamela
    Griffith, Karen
    Brown, Erica
    Eastman, Julie
    Zamba, Gideon
    Williams, Richard
    CANCER RESEARCH, 2015, 75
  • [5] Adenovirus PSA (Ad5-PSA) gene therapy for prostate cancer: A phase I clinical trial
    Lubaroff, DM
    Konety, BR
    Link, BK
    Madsen, TM
    Shannon, ME
    Ecklund, DJ
    O'Donnell, MA
    Ratliff, TL
    Williams, RD
    JOURNAL OF UROLOGY, 2003, 169 (04): : 395 - 395
  • [6] Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
    Lubaroff, David M.
    Konety, Badrinath R.
    Link, Brian
    Gerstbrein, Jack
    Madsen, Tammy
    Shannon, Mary
    Howard, Jeanne
    Paisley, Jennifer
    Boeglin, Diana
    Ratliff, Timothy L.
    Williams, Richard D.
    CLINICAL CANCER RESEARCH, 2009, 15 (23) : 7375 - 7380
  • [7] Phase I clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients
    Head, Jonathan F.
    Daniels, Gregory A.
    McKinney, Michelle
    Ongkeko, Weg
    Sakamoto, Kyoko
    Wang-Rodriguez, Jessica
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [8] Morphological changes induced by intraprostatic PSA-based vaccine in prostate cancer biopsies (phase I clinical trial)
    Merino, Maria J.
    Pinto, Peter A.
    Moreno, Vanessa
    Gil, Sara
    Schlom, Jeffrey
    Gulley, James L.
    HUMAN PATHOLOGY, 2018, 78 : 72 - 78
  • [9] Phase I Trial of a PSA based vaccine and ipilimumab in patients (pts) with metastatic castrate resistant prostate cancer (CRPC)
    Gulley, James L.
    Arlen, Philip M.
    Madan, Ravi
    Lechleider, Robert L.
    Dahut, William L.
    Lowy, Israel
    Schlom, Jeffrey
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3381S - 3381S
  • [10] PSA vaccine for prostate cancer
    Burton, A
    LANCET ONCOLOGY, 2002, 3 (06): : 329 - 329
12345